These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 15354005

  • 21. Individual differences in susceptibility to motion sickness among six Skylab astronauts.
    Graybiel A, Miller EF, Homick JL.
    Acta Astronaut; 1975; 2(1-2):155-74. PubMed ID: 11841091
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Mechanisms of antimotion sickness drugs.
    Wood CD, Manno JE, Wood MJ, Manno BR, Redetzki HM.
    Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
    [Abstract] [Full Text] [Related]

  • 26. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
    Graybiel A, Knepton J, Shaw J.
    Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of antimotion sickness drug side effects on performance.
    Wood CD, Manno JE, Manno BR, Redetzki HM, Wood MJ, Mims ME.
    Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
    [Abstract] [Full Text] [Related]

  • 32. Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.
    Patel PN, Ezzo DC.
    Am J Health Syst Pharm; 2009 Nov 15; 66(22):2024-6. PubMed ID: 19890085
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Coping with space motion sickness in Spacelab missions.
    Graybiel A.
    Acta Astronaut; 1981 Nov 15; 8(9-10):1015-8. PubMed ID: 11543090
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms.
    Cowings PS, Toscano WB.
    J Clin Pharmacol; 2000 Oct 15; 40(10):1154-65. PubMed ID: 11028255
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Use of promethazine to hasten adaptation to provocative motion.
    Lackner JR, Graybiel A.
    J Clin Pharmacol; 1994 Jun 15; 34(6):644-8. PubMed ID: 8083396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.